Engrave Wealth Partners LLC Biomarin Pharmaceutical Inc Transaction History

Engrave Wealth Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$71.87 - $131.03 $5,462 - $9,958	-76 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$79.55 - $124.22 $2,545 - $3,975	32 Added 72.73%	76 $9,000
Q1 2020 Apr 20, 2020	SELL	$71.37 - $96.85 $5,281 - $7,166	-74 Reduced 62.71%	44 $3,000
Q4 2019 Mar 12, 2020	BUY	$64.27 - $86.37 $7,583 - $10,191	118 New	118 $9,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Engrave Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Engrave Wealth Partners LLC with notifications on news.